Cerebral somatic oximeters are based on near-infrared spectroscopy (NIRS) technology. These devices are used for the pre and post-operative cardiac surgeries, vascular surgeries, and other surgeries. It is a non-invasive technology, which continuously monitors the cerebral tissue oxygen saturation and hemostasis of body. Cerebral somatic oximeter is also called the regional oximeter or tissue oximeter. It is a reliable technique for clinicians and provides help for efficient patient monitoring and prevention of adverse events.
Global Cerebral Somatic Oximeters Market Drivers
Increasing U.S. Food and Drug Administration (FDA) approvals for new cerebral somatic oximeters is expected to drive the global cerebral somatic oximeters market growth. For Instance, in May 2017, Masimo Company received the U.S. FDA approval for its new cerebral somatic oximeter (O3 Regional Oximetry Sensor), intended for the pediatric patients. These oximeters are used for the detection and correction of imbalances in oxygen delivery to the brain.
Furthermore, in May 2018, CAS Medical Systems, Inc. (CASMED) received U.S. Food and Drug Administration (FDA) approval for its new FORE-SIGHT Tissue Oximetry OEM (Original Equipment Manufacturer) Module.
Global Cerebral Somatic Oximeters Market Regional Analysis
North America is expected to hold dominant position in the global cerebral somatic oximeters market, owing to increasing validation study for cerebral somatic oximeters. For instance, in May 2017, National Institutes of Health (NIH) initiated validation study of the next generation cerebral and tissue oximeter (Desaturation), developed by Medtronic. The study is expected to complete in July 2019.
Furthermore, Asia Pacific is also projected to gain significant market value in the global cerebral somatic oximeters market during the forecast period, owing to increasing number of collaboration activities by various key players. For instance, in November 2016, Royal Philips collaborated with the Masimo Corporation. This collaboration includes the joint marketing and sales programs in Asia Pacific region for Masimo’s non-invasive sensor technologies, such as its rainbow and SET platforms. In future, Royal Phillips is expected to integrate with O3 regional oximetry and Nomoline capnography technologies in the Philips IntelliVue monitors.
Furthermore, Europe also expected to show significant growth in the global cerebral somatic oximeters market during the forecast period, owing to increasing number of approval activities for cerebral somatic oximeter. For instance, in April 2018, HyperMed Imaging, Inc. received CE marking from EEA (European Economic Area) for its new HyperView medical imaging system to distribute it in European market. The HyperView imaging system is a fast, handheld, battery operated, non-invasive, and portable diagnostic device, which is used to assess the detection of oxygen level in the brain.
Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2659
Key players operating in the global cerebral somatic oximeters market include Medtronic, Nonin Medical, CASMED, ISS, Inc., Masimo, Hamamatsu Photonics K.K., INVOS Ltd., and Ornim Medical.